表紙
市場調査レポート

現在および新興の細菌検査:新興のアッセイ、新技術および製品を開発する企業

2016-2020 Global Automated Microbiology Market: Emerging Tests and Companies Developing New Technologies and Products

発行 Venture Planning Group 商品コード 231300
出版日 ページ情報 英文 650 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。

Local License: 同一事業所内

Back to Top
現在および新興の細菌検査:新興のアッセイ、新技術および製品を開発する企業 2016-2020 Global Automated Microbiology Market: Emerging Tests and Companies Developing New Technologies and Products
出版日: ページ情報: 英文 650 Pages
概要

当レポートでは、細菌(微生物)検査市場について調査分析し、各疾患セグメントの概要と新技術、開発企業の概要などをまとめ、概略以下の構成でお届けします。

  • 第1章 AIDS
  • 第2章 アデノウイルス
  • 第3章 アエロモナス
  • 第4章 炭疽菌
  • 第5章 アルボウイルス
  • 第6章 バベシア症
  • 第7章 BEA
  • 第8章 Blastocystis Hominis
  • 第9章 ブルセラ菌
  • 第10章 カンピロバクター
  • 第11章 カンジダ
  • 第12章 シャーガス病
  • 第13章 軟性下疳
  • 第14章 クラミジア
  • 第15章 クロストリジウム・ディフィシレ
  • 第16章 コロナウイルス
  • 第17章 コクサッキーウイルス
  • 第18章 クロイツフェルト・ヤコブ病
  • 第19章 クリプトスポリジウム
  • 第20章 シクロスポラ
  • 第21章 サイトメガロ・ウイルス
  • 第22章 エボラウイルス
  • 第23章 大腸菌
  • 第24章 エコー・ウイルス
  • 第25章 脳炎
  • 第26章 エンテロウイルス
  • 第27章 エプスタイン・バーウイルス
  • 第28章 ランブル鞭毛虫
  • 第29章 淋病
  • 第30章 鼠径部肉芽腫
  • 第31章 ハンタウイルス
  • 第32章 ピロリ菌
  • 第33章 肝炎
  • 第34章 単純ヘルペスウイルス
  • 第35章 ヒトヘルペス・ウイルス6型
  • 第36章 インフルエンザウイルス
  • 第37章 レジオネラ
  • 第38章 ライム病
  • 第39章 鼠径リンパ肉芽腫
  • 第40章 マラリア
  • 第41章 はしか
  • 第42章 髄膜炎
  • 第43章 微胞子虫目
  • 第44章 単核症
  • 第45章 おたふく風邪
  • 第46章 マイコプラズマ
  • 第47章 パピロマウイルス
  • 第48章 パルボウイルス B19
  • 第49章 肺炎
  • 第50章 ポリオーマウイルス
  • 第51章 緑膿菌
  • 第52章 狂犬病
  • 第53章 呼吸器合胞体ウイルス
  • 第54章 ライノウイルス
  • 第55章 ロタウイルス
  • 第56章 風疹
  • 第57章 サルモネラ菌
  • 第58章 敗血症
  • 第59章 細菌性赤痢
  • 第60章 黄色ブドウ球菌
  • 第61章 連鎖球菌
  • 第62章 梅毒
  • 第63章 トキソプラズマ症
  • 第64章 膣トリコモナス
  • 第65章 結核
  • 第66章 ビブリオ
  • 第67章 西ナイルウイルス
  • 第68章 エルシニア
  • 図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMG18277

This 650-page report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.

Contains 650 pages and 47 tables

Table of Contents

1. AIDS

  • a. Background
    • Structure and Composition
    • Classification
    • Origin of AIDS
    • Animal Lentivirus Systems
    • Virus Receptos
    • HIV Infections in Humans
      • Pathogenesis & Pathology: Overview of HIV Infection Course
    • CD4T Lymphocytes and Memory Cells
    • Monocytes and Macrophages
    • Lymphoid Organs
    • Neural Cells
    • Viral Coinfections
      • Clinical Findings
    • Plasma Viral Load
    • Pediatric AIDS
      • Neurologic Disease
      • Opportunistic Infections
      • Cancer
    • Immunity
      • Virus Isolation
      • Serology
      • Detection of Viral Nucleic Acid and Antigens
    • Infectivity
    • Epidemiology
      • Worldwide Spread of AIDS
      • United States
      • Routes of Transmission
  • b. Diagnostic Tests
    • Laboratory Diagnosis
      • Enzyme Immunoassay Interpretation
      • Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
    • Competition Assays
    • Western Blot Technique
    • Immuno-Fluorescence Assay (IFA)
    • Radioimmunoprecipitation
    • HIV-1/HIV-2 Combination Testing
    • Methods of HIV-Antigen Detection
    • Antigen Assays and Blood Screening
    • Urine Tests
    • Immunopathogenic Mechanism of HIV Infection
    • DNA Probes
      • Overview
      • Quantitative Polymerase Chain Reaction
      • In Situ PCR
      • Needed Improvements
    • Viral Load/Drug Resistance Testing
    • Genotype and Phenotype Testing
    • Blood Banking Consideration
  • c. Vaccines and Drugs
    • Antiviral Drugs
      • Vaccines Against HIV
    • Transmission of HIV in Blood Products
    • HIV Transmission in Transplant and Artificial Insemination Recipients

2. Adenovirus

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
  • d. Adeno-Associated Viruses(AAV)

3. Aeromonas

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

5. Arboviruses

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

6. Babesiosis

  • a. Background

7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

8. Blastocystis Hominis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

9. Brucella

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

10. Campylobacter

  • a. Background
  • b. Diagnostic Tests
    • Identification from Culture
  • c. Vaccines and Drugs

11. Candida

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

12. Chagas Disease

  • a. Background

13. Chancroid

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

14. Chlamydia

  • a. Background
    • Chlamydia Psittaci
    • Chlamydia Pneumoniae
    • Chlamydia Trachomatis
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

15. Clostridium Difficile

  • a. Background
    • Pediatric Infections
    • Epidemiology
  • b. Diagnostic Tests
    • Counterimmunoelectrophoresis
    • Fluorescent-Antibody Assays
    • Poloymerase Chain Reactions
  • c. Drugs and Vaccines

16. Coronaviruses

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

17. Coxsackieviruses

  • a. Background
    • Herpangina
    • Hand-foot-and-mouth syndrome
    • Hepidemic Conjuctivitis
    • Pharingitis
    • Epidemic Pleurodynia
    • Myodarditis,Pericarditis
    • Overwhelming Infection of the Newborn
    • Acute Aseptic Meningitis
    • Undifferentiated Febrile Illness
    • Fever with upper respiratory infection
    • Encephalitis
    • Asymptomatic Infection
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

18. Creutzfeldt-Jakob's Disease

  • a. Background
    • Blood Transmission
  • b. Diagnostic Tests
    • Major Commercial and Academic Players
      • Bayer
      • Disease Sciences/Bio Tec Global
      • Imperial College of Medicine
      • Ortho-Clinical Diagnostics
      • Pall
      • ProMetic Life Sciences
      • Proteome Sciences/Idexx
      • Q-One Biotech
      • Serono
      • U.S. Agricultural Research Service
  • c. Vaccines

19. Cryptosporidium Parvum

  • a. Background
  • b. Diagnostic Tests
    • Histologic
    • Laboratory Parasitology
    • Serodiagnosis
  • c. Vaccines and Drugs

20. Cyclospora Cayetanensis

  • a. Background
    • Asymptomatic Infection
    • Diarrhea in Immunocompetent Persons
    • Diarrhea in Immunocompromisedersons
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

21. Cytomegalovirus

  • a. Background
    • Chorioretinitis
    • Gastrointestinal
    • Central Nervous System Disease
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

22. Ebola Virus

  • a. Background
    • Epidemiology
    • Hemorrhagic Fever
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

23. E. Coli

  • a. Background
    • Role of Escherichia Coli in
  • Causing Diarrhea
    • EPEC
    • ETEC
    • EIEC
    • EHEC
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

24. EchoVirus

  • a. Background
    • Acute Aseptic Miningitisis
    • Encephalitis
    • Exanthems
    • Respiratory Disease
    • Myope;ricarditis
    • Neonatal Infections
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

25. Encephalitis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

26. Enteroviruses

  • a. Background
  • b. Diagnostic Tests
    • Viral Isolation and Identification
    • Antibody Tests
  • c. Vaccines and Drugs

27. Epstein-Barr Virus

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

28. Giardia Lamblia

  • a. Background
    • Life Cycle and Morphology
    • Morphology of Trophozoites
    • Clinical Disease
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

29. Gonorrhea

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

30. Granuloma Inguinale

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

31. Hantavirus

  • a. Background
    • Identification of the Agent
    • Transmission
    • Other Rodent Hantaviruses
    • Distribution
    • Hantavirus Diseases
    • Epidemiology
    • Addendum in Proof-Northeastern Connection
    • Previously Unknown Pathogens
    • Cases Nationwide
  • b. Diagnostic Tests
    • An Immunohistochemistry Approach
    • Hantavirus Rapid Diagnostic Test
    • ELISA Diagnosis of Hantavirus Pulmonary Syndrome
    • IgG ELISA
    • IgM Capture ELISA
  • c. Vaccines and Drugs

32. Helicobacter Pylori

  • a. Background
    • Pathogenesis
    • Role in Peptic Ulcer Disease
    • Role in Gastric Cancer
    • Nonulcer Dyspepsia
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Specific Therapeutic Regimens
    • Who Should Be Treated?
    • Participants in Controlled Clinical Trials
    • Patients with Refractory Peptic Ulcer
    • Patients with Refractory NUD
    • Patients in High-Risk Groups for Gastric Cancer

33. Hepatitis

  • a. Background
  • b. Hepatitis A
  • c. Hepatitis B
  • d. Hepatitis C
    • Classification
    • Transmission of Infection
    • Occupational Hazards
    • Acute Hepatitis
    • Diagnosis of Acute Infection
    • Chronic Hepatitis
    • HCV and Other Chronic Liver Diseases
    • Alcoholic Liver Disease
    • Hepatitis B Coinfection
    • Cirrhosis and Hepatocellular Carcinoma
    • Diagnostic Tests
    • Possible Indications for HCV RNA Testing
    • Conclusions and Future Direction
  • e. Hepatitis D
    • Historical Perspective
    • Epidemiology
    • HBV-HDV "Coinfection" vs. "Superinfection"
    • Methods of Detecting HDV
    • Prevention
  • f. Hepatitis E
    • Background
    • Prevalence of the Disease
    • Diagnostic Tests
    • Epidemiologic Serosurveys
    • Serologic Cross-Reactivity
  • g. Hepatitis G
    • Vaccines and Drugs

34. Herpes Simplex Virus

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

35. Human Herpes Virus-6 (HHV-6)

  • a. Background
    • HIV-6 Infections
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

36. Influenza Viruses

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

37. Legionella

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

38. Lyme Disease

  • a. Background
    • Clinical Description
    • Clinical Case Definition
    • Laboratory Criteria for Diagnosis
    • Case Classification
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

39. Lymphogranuloma Venereum (LGV)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

40. Malaria

  • a. Background
  • b. Diagnostic Tests
    • Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
      • Patient
      • Laboratory
      • Physician
  • c. Vaccines and Drugs

41. Measles (Rubeola)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

42. Meningitis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Development of Polysaccharide Vaccines
    • Quadrivalent Vaccine Development
    • Meningococcal A.C.Y. & W-135 Vaccines
    • Efficacy of Group C Vaccine
    • Efficacy of Group A Vaccine
    • Combinations of Group A and C Vaccines
    • Group B Efficacy Trials
    • Future Direction

43. Microsporidium

  • a. Background
    • Prevalence and Geographic Distribution
    • Sources of Human Infection and Transmission
  • b. Diagnostic Tests
    • Light Microscopic Examination of Stool Specimens By Chromotrope Staining
    • Stool Concentration Methods
    • Chemofluorescent Agents
    • Giemsa Staining of Stool Specimens
    • Cytologic Diagnosis
    • Histologic Examination
    • Electron Microscopy
    • Examination of Bodily Fluids
    • Examination of Tissue Sections
    • Immunofluorescence Detection Procedures
    • Serology
    • Cell Culture
    • Approach to Diagnosis
    • Evaluation of Patients with Presumptive Intestinal Microsporidiosis
    • Evaluation of Patients with Presumptive Ocular Microsporidiosis
  • c. Vaccines and Drugs

44. Mononucleosis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

45. Mumps

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Efficacy of Vaccination
    • Future Issues

46. Mycoplasma

  • a. Background
    • Ureaplasma Urealyticum & Mycoplasma Hominis
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

47. Papillomaviruses

  • a. Background
    • HPV in Cancer
    • Cervical Neoplasm
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Prevention

48. Parvovirus B19

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

49. Pneumonia

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

50. Polyomaviruses

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

51. Pseudomonas Aeruginosa

  • a. Background
    • Virulence Factors
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

52. Rabies

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

54. RhinoViruses

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

56. Rubella(MEASLES)

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Developing Countries
    • Elimination and Eradication of Measles
    • New Developments

57. Salmonellosis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

58. Septicemia

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

59. Shigellosis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

60. Staphylococcus Aureus

  • a. Background
    • The Genus Taphylococcus
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Prevention

61. Streptococci

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
    • Group A Streptococci
    • Group B Streptococci

62. Syphilis

  • a. Background
  • b. Diagnostic Tests
    • Biopsy
    • Rabbit Infectivity Testing
    • Other Diagnostic Modalities
  • c. Vaccines and Drugs
    • Syphilis and HIV Infection
    • Syphilis As a Cofactor for HIV Transmission
    • Basic Science Issues

63. Toxoplasmosis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

64. Trichomonas Vaginalis

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

65. Tuberculosis

  • a. Background
  • b. Diagnostic Tests
    • Microscopic Characteristics
    • Cultural Characteristics
    • Detection of Antibodies
    • Skin Tests
    • MDRTB
  • c. Vaccines and Drugs

66. Vibrio

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

67. West Nile Virus

  • a. Background
    • Clinical Syndromes
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

68. Yersina

  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top